CardioNet, Inc. Provides Update on Mobile Cardiovascular Telemetry Reimbursement
October 30 2009 - 6:45PM
Business Wire
CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical
technology company with an initial focus on the diagnosis and
monitoring of cardiac arrhythmias, announced today that the Centers
for Medicare and Medicaid Services (“CMS”) has not established a
national pricing reimbursement rate for mobile cardiovascular
telemetry (CPT Code 93229) in the Medicare final rule for the
physician fee schedule for calendar year 2010. Reimbursement for
mobile cardiovascular telemetry will continue to be carrier priced
by Highmark Medicare Services (“HMS”).
Randy Thurman, Chairman, President and Chief Executive Officer
of CardioNet, stated, “We are extremely disappointed that CMS has
not established a national reimbursement rate for mobile
cardiovascular telemetry and that it will continue to be regionally
priced by HMS. CardioNet and other industry providers have now
serviced nearly 400,000 patients nationally, of which a significant
portion were Medicare patients. Since the unexpected announcement
by Highmark on July 10, 2009, we provided CMS and HMS with
substantial data that we believe justified a significantly higher
national reimbursement rate and we will continue to work with CMS
on a national price for 2011.”
CMS also updated the national technical fees for event and
Holter monitoring for the calendar year 2010. Event monitoring (CPT
Code 93271) and Holter monitoring (CPT Code 93226) reimbursement
will be reduced approximately 7% and 16%, respectively, compared to
the 2009 rates.
About CardioNet
CardioNet is the leading provider of ambulatory, continuous,
real-time outpatient management solutions for monitoring relevant
and timely clinical information regarding an individual's health.
CardioNet's initial efforts are focused on the diagnosis and
monitoring of cardiac arrhythmias, or heart rhythm disorders, with
a solution that it markets as Mobile Cardiac Outpatient TelemetryTM
(MCOT™). More information can be found at
http://www.cardionet.com.
Forward-Looking Statements
This press release includes certain forward-looking statements
within the meaning of the "Safe Harbor" provisions of the Private
Securities Litigation Reform Act of 1995 regarding, among other
things, our growth prospects, the prospects for our products and
our confidence in the Company's future. These statements may be
identified by words such as "expect," "anticipate," "estimate,"
"intend," "plan," "believe," "promises" and other words and terms
of similar meaning. Such forward-looking statements are based on
current expectations and involve inherent risks and uncertainties,
including important factors that could delay, divert, or change any
of them, and could cause actual outcomes and results to differ
materially from current expectations. These factors include, among
other things, changes in governmental regulations and legislation,
changes to reimbursement levels for our products, including the
potential for re-evaluation from Highmark or CMS on reimbursement,
the success of our sales and marketing initiatives, our ability to
attract and retain talented executive management and sales
personnel, our ability to identify acquisition candidates, acquire
them on attractive terms and integrate their operations into our
business, the commercialization of new products, market factors,
internal research and development initiatives, partnered research
and development initiatives, competitive product development, the
continued consolidation of payors, acceptance of our new products
and services and patent protection and litigation. For further
details and a discussion of these and other risks and
uncertainties, please see our public filings with the Securities
and Exchange Commission, including our latest periodic reports on
Form 10-K and 10-Q. We undertake no obligation to publicly update
any forward-looking statement, whether as a result of new
information, future events, or otherwise.
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jun 2024 to Jul 2024
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jul 2023 to Jul 2024